These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9242544)

  • 41. Establishment of a murine leukemia L1210-specific T-cell clone displaying novel in vivo anti-tumor activity.
    Nagase F; Ueda K; Nakashima I; Kawashima K; Isobe K; Nagura E; Yamada K; Yokochi T; Hasegawa Y; Yoshida T
    Int J Cancer; 1986 Dec; 38(6):907-14. PubMed ID: 3491792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between amine-carboxyboranes and TNF alpha for the regulation of cell growth in different tumor cell lines.
    Miller MC; Woods CM; Murphy ME; Elkins A; Spielvogel BF; Hall IH
    Biomed Pharmacother; 1998; 52(4):169-79. PubMed ID: 9755812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of cytotoxic activity of the CD4+ T lymphocytes generated by local immunotherapy.
    Katsumoto Y; Monden T; Takeda T; Haba A; Ito Y; Wakasugi E; Wakasugi T; Sekimoto M; Kobayashi T; Shiozaki H; Shimano T; Monden M
    Br J Cancer; 1996 Jan; 73(1):110-6. PubMed ID: 8554971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N-acetylcysteine inhibits activation of toll-like receptor 2 and 4 gene expression in the liver and lung after partial hepatic ischemia-reperfusion injury in mice.
    Jin X; Wang L; Wu HS; Zhang L; Wang CY; Tian Y; Zhang JH
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):284-9. PubMed ID: 17548252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of cytotoxic T-lymphocytes in the antitumor activity of spergualin against L1210 cells.
    Umezawa H; Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T
    Cancer Res; 1987 Jun; 47(12):3062-5. PubMed ID: 3495325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-10-induced HIV-1 expression is mediated by induction of both membrane-bound tumour necrosis factor (TNF)-alpha and TNF receptor type 1 in a promonocytic cell line.
    Barcellini W; Rizzardi GP; Marriott JB; Fain C; Shattock RJ; Meroni PL; Poli G; Dalgleish AG
    AIDS; 1996 Jul; 10(8):835-42. PubMed ID: 8828740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [N-acetylcysteine antagonizes the Interleukin-18-induced expression of TNF-alpha and IL-6 in mouse vascular smooth muscle cells].
    Zhang SQ; Luo X; Huang HL; Chai Y; Hu DJ; Tao QS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jan; 26(1):35-7. PubMed ID: 20056085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide.
    Ohminami H; Yasukawa M; Kaneko S; Yakushijin Y; Abe Y; Kasahara Y; Ishida Y; Fujita S
    Blood; 1999 Feb; 93(3):925-35. PubMed ID: 9920842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
    Toomey NL; Deyev VV; Wood C; Boise LH; Scott D; Liu LH; Cabral L; Podack ER; Barber GN; Harrington WJ
    Oncogene; 2001 Oct; 20(48):7029-40. PubMed ID: 11704827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of cell-mediated cytotoxicity by recombinant tumor necrosis factor (TNF alpha).
    Shimamoto Y; Pichyangkul S; Khan A
    Proc Soc Exp Biol Med; 1988 Dec; 189(3):310-6. PubMed ID: 3205882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo.
    Bowlin TL; Prakash NJ; Edwards ML; Sjoerdsma A
    Cancer Res; 1991 Jan; 51(1):62-6. PubMed ID: 1988107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Membrane lymphotoxin is required for resistance to Theiler's virus infection.
    Lin X; Ma X; Rodriguez M; Feng X; Zoecklein L; Fu YX; Roos RP
    Int Immunol; 2003 Aug; 15(8):955-62. PubMed ID: 12882833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-acetylcysteine attenuates TNF-alpha-dependent reduction of IL-4-induced Fc epsilon RII expression in human monocytes.
    Hashimoto S; Gon Y; Nakayama T; Yoshida S; Hayashi S; Maruoka S; Yodoi J; Horie T
    Allergy; 1997 Sep; 52(9):909-13. PubMed ID: 9298175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sulfasalazine inhibits the binding of TNF alpha to its receptor.
    Shanahan F; Niederlehner A; Carramanzana N; Anton P
    Immunopharmacology; 1990; 20(3):217-24. PubMed ID: 1981213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Boric acid inhibits LPS-induced TNF-alpha formation through a thiol-dependent mechanism in THP-1 cells.
    Cao J; Jiang L; Zhang X; Yao X; Geng C; Xue X; Zhong L
    J Trace Elem Med Biol; 2008; 22(3):189-95. PubMed ID: 18755394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Muramyl peptides augment cytotoxic effect of tumor necrosis factor-alpha in combination with cytotoxic drugs on tumor cells.
    Petrova EE; Valyakina TI; Simonova MA; Komaleva RL; Khaidukov SV; Makarov EA; Blokhin DY; Ivanov PK; Andronova TM; Nesmeyanov VA
    Int Immunopharmacol; 2006 Sep; 6(9):1377-86. PubMed ID: 16846831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Supraoptimal peptide-major histocompatibility complex causes a decrease in bc1-2 levels and allows tumor necrosis factor alpha receptor II-mediated apoptosis of cytotoxic T lymphocytes.
    Alexander-Miller MA; Derby MA; Sarin A; Henkart PA; Berzofsky JA
    J Exp Med; 1998 Oct; 188(8):1391-9. PubMed ID: 9782116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Downregulation of STAT3 phosphorylation enhances tumoricidal effect of IL-15-activated dendritic cell against doxorubicin-resistant lymphoma and leukemia via TNF-α.
    Hira SK; Mondal I; Bhattacharya D; Gupta KK; Manna PP
    Int J Biochem Cell Biol; 2015 Oct; 67():1-13. PubMed ID: 26255115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.